Medicaid Managed CareMay 21, 2025
Medical Policies and Clinical Utilization Management Guidelines update
Effective June 25, 2025
The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third‑Party Criteria below were developed and/or revised with expanded rationales, medical necessity indications, or criteria. Some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary.
Please share this notice with other members of your practice and office staff.
To view a guideline, visit the Medical Policies and Clinical UM Guidelines page.
Medical Policies
The medical policy and technology assessment committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect June 25, 2025.
Publish date | Medical Policy number | Medical Policy title | Status |
1/30/2025 | DME.00011 | Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices | Revised |
1/30/2025 | LAB.00037 | Serologic Testing for Biomarkers of Irritable Bowel Syndrome (IBS) | Revised |
4/10/2024 | SURG.00140 | Peripheral Nerve Blocks for Treatment of Neuropathic Pain | Reviewed |
Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
OHBCBS-CD-083090-25-CPN82473
PUBLICATIONS: June 2025 Provider Newsletter
To view this article online:
Or scan this QR code with your phone